Stay updated on Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial page.

Latest updates to the Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial page
- Check5 days agoChange DetectedThe bottom revision stamp updates from v3.5.3 to v3.5.4, reflecting a new revision of the record history. This indicates the study record has been updated.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedUpdated the ClinicalTrials.gov interface/revision label from **v3.5.2** to **v3.5.3**.SummaryDifference0.1%

- Check33 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 in the history.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision v3.4.3 was added and revision v3.4.2 was removed from the record history. This reflects a version-control update to the study record rather than a change to study content.SummaryDifference0.1%

- Check100 days agoChange DetectedAdded revision v3.4.2 and removed revision v3.4.1 in the history.SummaryDifference0.1%

Stay in the know with updates to Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial page.